Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Traupe

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Cardiovascular Research|February 27, 2004
Protease-activated receptors and EDHF: the icing on the cake?Tobias Traupe, Matthias Barton
Circulation|June 15, 2011
Letter by Gloekler et al regarding article, "Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study"Steffen Gloekler, Tobias Traupe, Christian Seiler
Coronary Artery Disease|October 17, 2003
Endothelin, hypercholesterolemia and atherosclerosisMatthias Barton, Tobias Traupe, Christian C Haudenschild
Expert Opinion on Investigational Drugs|February 28, 2002
Oral contraceptives and the risk of thrombosis and atherosclerosisMatthias Barton, Raghvendra K Dubey, Tobias Traupe
Current Vascular Pharmacology|August 24, 2004
Endothelial therapy of atherosclerosis and its risk factorsTobias Traupe, Jana Ortmann, Klaus Münter, et al.
Trends in Cardiovascular Medicine|February 22, 2011
Physical coronary arteriogenesis: a human "model" of collateral growth promotionRolf Vogel, Tobias Traupe, Valérie Stolt Steiger, et al.
European Journal of Clinical Investigation|October 14, 2018
The effect of pegylated granulocyte colony-stimulating factor on collateral function and myocardial ischaemia in chronic coronary artery disease: A randomized controlled trialTobias Traupe, Michael Stoller, Steffen Gloekler, et al.
Biochemical and Biophysical Research Communications|February 21, 2003
Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growthLuca Emmanuele, Jana Ortmann, Tim Doerflinger, et al.
Journal of Vascular Surgery|November 25, 2011
Gender is an independent risk factor for distribution pattern and lesion morphology in chronic critical limb ischemiaJana Ortmann, Eveline Nüesch, Tobias Traupe, et al.
Plos One|October 12, 2012
Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapyAli Al Kaabi, Tobias Traupe, Monika Stutz, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Cardiovascular Research|February 27, 2004
Protease-activated receptors and EDHF: the icing on the cake?Tobias Traupe, Matthias Barton
Circulation|June 15, 2011
Letter by Gloekler et al regarding article, "Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study"Steffen Gloekler, Tobias Traupe, Christian Seiler
Coronary Artery Disease|October 17, 2003
Endothelin, hypercholesterolemia and atherosclerosisMatthias Barton, Tobias Traupe, Christian C Haudenschild
Expert Opinion on Investigational Drugs|February 28, 2002
Oral contraceptives and the risk of thrombosis and atherosclerosisMatthias Barton, Raghvendra K Dubey, Tobias Traupe
Current Vascular Pharmacology|August 24, 2004
Endothelial therapy of atherosclerosis and its risk factorsTobias Traupe, Jana Ortmann, Klaus Münter, et al.
Trends in Cardiovascular Medicine|February 22, 2011
Physical coronary arteriogenesis: a human "model" of collateral growth promotionRolf Vogel, Tobias Traupe, Valérie Stolt Steiger, et al.
European Journal of Clinical Investigation|October 14, 2018
The effect of pegylated granulocyte colony-stimulating factor on collateral function and myocardial ischaemia in chronic coronary artery disease: A randomized controlled trialTobias Traupe, Michael Stoller, Steffen Gloekler, et al.
Biochemical and Biophysical Research Communications|February 21, 2003
Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growthLuca Emmanuele, Jana Ortmann, Tim Doerflinger, et al.
Journal of Vascular Surgery|November 25, 2011
Gender is an independent risk factor for distribution pattern and lesion morphology in chronic critical limb ischemiaJana Ortmann, Eveline Nüesch, Tobias Traupe, et al.
Plos One|October 12, 2012
Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapyAli Al Kaabi, Tobias Traupe, Monika Stutz, et al.
Pageof 5